GHK-Cu

The world's first orally bioavailable GHK-Cu Copper peptide capsules - combined with the Palmitoylethanolamide (PEA), Stomach acid buffer/Peptide absorption enhancers

SNAC + Sodium Bicarbonate in acid-resistant delayed-release, enteric-coated capsules to optimise oral delivery.

Normally GHK-Cu in its raw form is not effective orally as this tripeptide doesn't withstand the stomach acid nor the proteolytic enzymes in the stomach; but by protecting the peptide with SNAC, Sodium bicarbonate and delayed release, enteric-coated capsules a large percentage of the GHK-Cu peptide can pass these barriers to administration and be delivered to the GI tract and absorbed in tact for systemic benefit.

Palmitoylethanolamide (PEA) is a naturally occurring fatty acid that has been studied to show neuroprotective, anti-inflammatory, antihistamine/mast cell stabilizing, and analgesic properties. PEA may also provide relief from acute and chronic pain, and may significantly reduce inflammation via interacting with all of the following receptors: CB1, CB2, PPARa, GRR55, TRPV1, and COX2.

Sodium bicarbonate and Salcaprozate Sodium (SNAC) plus use of Delayed Release (DR) acid-resistant capsules are all used to resist and buffer stomach acidity and to maximize the absorption of the GHK-Cu peptide. In the stomach, the digestive enzyme pepsin can break down the GHK peptide, but this only occurs at low pH, therefore adding SNAC + Bicarb to buffer acidity may substantially improve absorption and maximize oral delivery even if the acid-resistant DR capsules break or open.

Note: GHK-Cu (Copper Tripeptide) is an experimental biological peptide and as such ingestion or use of this product is for experimental purposes ONLY LVLUP Health makes no health or therapeutic claims and assumes no responsibility or liability for health effects, positive or negative, that may result from consuming this product; do so at own risk.